Ex-government leader Sunak has strengthened his appeal for a focused screening programme for prostate cancer.
During a recent interview, he expressed being "certain of the urgency" of introducing such a system that would be affordable, feasible and "preserve numerous lives".
His remarks come as the National Screening Advisory Body reevaluates its determination from half a decade past declining to suggest regular testing.
Media reports suggest the body may continue with its present viewpoint.
Athlete Adds Support to Movement
Gold medal cyclist Sir Hoy, who has advanced prostate cancer, wants middle-aged males to be tested.
He recommends reducing the minimum age for requesting a PSA blood test.
Presently, it is not automatically provided to healthy individuals who are below fifty.
The prostate-specific antigen screening remains debated however. Readings can increase for causes apart from cancer, such as infections, leading to incorrect results.
Opponents argue this can result in needless interventions and complications.
Focused Screening Initiative
The recommended testing initiative would focus on males between 45 and 69 with a family history of prostate gland cancer and African-Caribbean males, who encounter twice the likelihood.
This population encompasses around over a million men in the UK.
Organization calculations suggest the programme would require £25 million a year - or about £18 per person per individual - similar to colorectal and mammary cancer screening.
The estimate includes 20% of qualified individuals would be contacted yearly, with a seventy-two percent uptake rate.
Diagnostic activity (scans and tissue samples) would need to increase by twenty-three percent, with only a modest expansion in medical workforce, as per the study.
Medical Community Response
Various medical experts are sceptical about the effectiveness of testing.
They contend there is still a chance that men will be medically managed for the condition when it is not absolutely required and will then have to experience side effects such as bladder issues and impotence.
One respected urology professional stated that "The problem is we can often find abnormalities that doesn't need to be treated and we potentially create harm...and my worry at the moment is that risk to reward equation requires refinement."
Individual Experiences
Individual experiences are also affecting the debate.
One instance involves a 66-year-old who, after asking for a blood examination, was diagnosed with the cancer at the time of fifty-nine and was informed it had spread to his hip region.
He has since received chemo treatment, radiotherapy and hormone treatment but cannot be cured.
The patient supports examination for those who are potentially vulnerable.
"This is essential to me because of my boys – they are in their late thirties and early forties – I want them screened as promptly. If I had been screened at fifty I am confident I wouldn't be in the situation I am today," he commented.
Future Steps
The National Screening Committee will have to assess the data and arguments.
While the new report says the ramifications for personnel and capacity of a testing initiative would be manageable, some critics have contended that it would take imaging resources from individuals being managed for other conditions.
The ongoing debate highlights the complicated equilibrium between timely diagnosis and potential overtreatment in prostate gland cancer management.
